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Pre-endoscopy scoring systems do not take into account whether
bleeding is from varices because that is unknown before
endoscopy. Several risk scoring systems, however, such as the
Glasgow Blatchford score and admission Rockall score include
underlying liver disease (and other comorbidities) as variables.
In addition, and as Dib notes,1 the AIMS65 score includes
albumin and international normalised ratio, which are often
altered in patients with liver disease.
Any patient with chronic liver disease is at higher risk of poor
outcome with or without bleeding from varices, which is why
a history or markers of liver disease are usually included in
gastrointestinal bleeding scores. It is correct that 143 of the
patients in our study had a variceal source of bleeding confirmed
at endoscopy.2 However, the study aimed to assess the clinical
utility of risk scores, including very early assessment using the
three pre-endoscopy risk scores assessed. The pre-endoscopy
AIMS65 score and post-endoscopy PNED were best at
predicting 30 day mortality at thresholds 2 and 4, respectively,
although areas under the receiver operating characteristic curve
were <0.80. If patients have a degree of liver decompensation
leading to both a low albumin and a raised international
normalised ratio, they will score at least 2 in the AIMS65 score.
However, patients with compensated cirrhosis who might bleed
from varices often have normal albumin or international
normalised ratio, or both. Therefore we do not think that this
issue affects the results of our study in predicting mortality.
Mortality after variceal bleeding is largely dependent on the
severity of underlying liver disease as measured by Child-Pugh’s
classification or the model for end stage liver disease scoring
rather than by standard upper gastrointestinal bleeding risk
scores. However, our results are an opportunity to assess the
ability of the risk scores studied to predict outcome in patients
with variceal bleeding, and we are currently analysing this
subgroup with the aim of writing a short article on this.
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